Berlin Science Week: "Starting Up Science: From Lab to Therapy" with 2020 Heinrich Wieland Prize laureate Craig M. Crews

STARTING UP SCIENCE: FROM LAB TO THERAPY

BOEHRINGER INGELHEIM STIFTUNG

How can ideas spawned by curiosity-driven research bring about new treatment options? Speaking live from Yale University, 2020 Heinrich Wieland Prize laureate Craig M. Crews discusses his experiences with scientists from Germany. Be there and join in the discussion!

What path does an idea spawned by curiosity-driven research take from lab to real-world treatment? How do science-based start-ups succeed in the US and in Germany? These and other questions will be discussed during this virtual meeting organised by the Boehringer Ingelheim Foundation. Our special guest at the event is Heinrich Wieland Prize winner Craig M. Crews. The chemist and professor at Yale University is a pioneer in the field of controlled protein degradation. His early research led to an FDA-approved drug used to treat multiple myeloma. More recently, he developed a new technology that allows destruction of disease-associated proteins that so far remained intractable, paving the way for entirely new treatment options. Arvinas, the start-up founded on the basis of this technology, is currently conducting initial clinical trials of new treatments for metastatic prostate and breast cancer. At the event, Craig M. Crews will meet with scientists from Germany who have also founded start-ups: What framework do they need? What helped and what hindered their undertaking? At the end, we will invite the audience to participate in the discussion and share their own experiences.

Public Discussion via livestream, followed by a Q&A session on Zoom.